Anticorps Recombinant de lapin anti-GPSM2

GPSM2 Recombinant Antibody for WB, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

250793G2

N° de cat : 86175-1-PBS

Synonymes

G protein signaling modulator 2, G-protein-signaling modulator 2, LGN, Pins



Informations sur le produit

86175-1-PBS cible GPSM2 dans les applications de WB, Indirect ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène GPSM2 Protéine recombinante Ag25195
Nom complet G-protein signaling modulator 2 (AGS3-like, C. elegans)
Masse moléculaire calculée 75 kDa
Poids moléculaire observé70-77 kDa
Numéro d’acquisition GenBankBC027732
Symbole du gène GPSM2
Identification du gène (NCBI) 29899
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

GPSM2 belongs to a family of proteins that modulate activation of G proteins. GPSM2 assists in the exchange of guanine nucleotides, and allows extracellular signals to be transmitted to cells via cell surface, and ultimately plays a key role in the activation of G-proteins. Therefore, GPSM2 is a critical factor for the stability of cell division. Some recent studies have shown that GPSM2 messenger RNA (mRNA) is overexpressed and plays a positive role in the development of certain tumors, such as liver cancer, pancreatic cancer, breast cancer. It also plays a role in neuroblast division and in the development of normal hearing. Mutations in GPSM2 are associated with autosomal recessive nonsyndromic deafness (DFNB82), which is a form of non-syndromic deafness characterized by prelingual, bilateral, severe, sensorineural hearing loss.

{{ptg:RelatedPrimaryAntibodies}}